Synageva moves headquarters to Lexington, Mass.

09/17/2010 | Boston Globe (tiered subscription model), The

Synageva BioPharma has transferred its headquarters to a larger facility in Lexington, Mass., to provide more space for the development of its experimental drugs for rare diseases. One of the drugs included in the company's pipeline is SBC-102, an enzyme replacement treatment for lysosomal acid lipase deficiency.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care